Exagen Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Outlook Above Estimates.
Exagen Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Outlook Above Estimates.
exagen股價上漲，公司報告Q2財務業績優於預期並將FY24營業收入預期上調。
Exagen Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Outlook Above Estimates.
exagen股價上漲，公司報告Q2財務業績優於預期並將FY24營業收入預期上調。